 Cytokine receptors selectively activate particular JAK-STAT pathways to induce transcription of different genes.IL-2 and IL-4 activate JAK1, JAK3 and STAT5.JAK3 activating mutations are found in 16% of T-cell acute lymphoblastic leukemia (T-ALL) patients.